Abstract
Cardiovascular diseases (CVDs) remain a leading cause of mortality worldwide, posing a significant public health challenge. Early identification of individuals at high risk of CVD is crucial for timely intervention and prevention strategies. Machine learning techniques are increasingly being applied in healthcare for their ability to uncover complex patterns within large, multidimensional datasets. This study introduces a novel ensemble meta-learning framework designed to enhance cardiovascular disease (CVD) risk prediction. The framework strategically combines the predictive power of diverse machine learning algorithms – logistic regression, K nearest neighbors, decision trees, gradient boosting, gaussian Naive Bayes and XGBoost. Predicted probabilities from these base models are integrated using support vector machine as meta-learner. Rigorous performance evaluation over publicly available dataset demonstrates the improved performance of this ensemble approach compared to individual. This research highlights the potential of ensemble meta-learning techniques to improve predictive modeling in healthcare.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was supported by the ABV-Indian Institute of Information Technology and Management Gwalior (ABV-IIITM) under a faculty investment grant (file no. ABV-IIITM/DoRC/FIG/ 2023/2526). The authors are affiliated with the Department of Computer Science and Engineering, ABV-IIITM Gwalior.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Data is publicly accessible.
https://www.kaggle.com/datasets/sulianova/cardiovascular-disease-dataset
